Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: February 2016

Centenary College Names David P. Haney as 13th President

David Haney centenary collegeHackettstown, NJ, February 23, 2016 ― The Centenary College Board of Trustees announced that Dr. David P. Haney has been named the 13th president of the northwestern New Jersey based institution effective as of July 1, 2016.

Dr. Haney will relinquish his position as Vice President for Academic Affairs at Emory & Henry College, a liberal arts college in Southwest Virginia.

“Dr. Haney has the stellar reputation of being an excellent administrator and an effective, collaborative leader,” says Wolfgang Gstattenbauer ‘84/13HA, Chair of the Board of Trustees and Presidential Search Committee Chair.  Continue reading

In States, A Rising Call to Promote STEM Education and Cut Liberal Arts Funding

STEM 1New York, NY, February 22, 2016 ― Frustrated by soaring tuition costs, crushing student loan debt and a lack of skilled workers, particularly in science and technology, more and more states have adopted the idea of rewarding public colleges and universities for churning out students educated in fields seen as important to the economy reports Patricia Cohen in The New York Times

When it comes to dividing the pot of money devoted to higher education, at least 15 states offer some type of bonus or premium for certain high-demand degrees, according to the National Conference of State Legislatures.

What has incensed many educators is not so much the emphasis on work force development but the disdain for the humanities, particularly among Republicans.  Several Republicans have portrayed a liberal arts education as an expendable, sometimes frivolous luxury that taxpayers should not be expected to pay for. Continue reading

Rowan University and AtlantiCare Explore Feasibility of an Atlantic City Medical School

Glassboro, NJ, February 22, 2016 ― Andrew Sheldon reports in NJBIZ that Rowan University, in partnership with AtlantiCare Health System, has procured the services of the Tripp Umbach consulting company to determine the feasibility of a new school of osteopathic medicine, which would be located in Atlantic City.

“This is the first step,” said Joe Cardona, vice president for university relations at Rowan. “We both agree we’re serious about the possibility of this happening.” Continue reading

PhRMA Video Focuses on Biopharmaceutical R&D; Failures Lead to Successes

Research 1Washington, DC, February 21, 2015 ― The Pharmaceutical Research and Manufacturers of America (PhRMA) released a video on the research and development (R&D) of new, innovative medications.

PhRMA’s Holly Campbell reports on The Catalyst, the PhRMA’s blog, that prescription medicines save lives and cut health care costs.  However, conjuring a drug to life is a challenging undertaking — and the science is only getting harder.

While it may sound counterintuitive, as our understanding of science grows, so does the complexity of developing new medicines — particularly as treatments are increasingly tailored to the unique needs of individual patients. Continue reading

Two Rutgers Scientists Among Four Receiving $600,000 from QED Proof-of-Concept Program

Rutgers RNew Brunswick, NJ, February 20, 2016 ― Researchers — including two from Rutgers University — that are developing technologies that could lead to new gene and cell therapies, and that will help nurses and physical therapists do their jobs more effectively, will receive a total of $600,000 in funding through the eighth round of the University City Science Center’s QED Proof-of-Concept Program.

The program, started in 2009, funds novel university technologies with market potential, bridging the gap between academic research and product commercialization. The awardees were selected from a pool of 62 applicants and 12 universities in the Greater Philadelphia region. Continue reading

AdvaMed Names Scott Whitaker CEO and President

Scott Whitaker AdvaMed CEOWashington, DC, February 19, 2016 ― The Board of Directors of the Advanced Medical Technology Association (AdvaMed) announced yesterday that Scott Whitaker will be its next president and chief executive officer effective April 4, 2016.

Whitaker joins AdvaMed, the world’s leading association for medical technology companies, having served most recently as chief operating officer of the Biotechnology Innovation Organization (BIO).

“We are very pleased that Scott has agreed to lead AdvaMed at a time of unprecedented change in health care,” said AdvaMed Board Chairman Vincent A. Forlenza, chairman, CEO and president of BD. Continue reading

The Dream of 3D-Printed Organs Depends on Keeping Cells Alive—A New Advance Could Help

STATBoston, MA, February 17, 2016 ― Rebecca Robbins reports on STAT that there is plenty of excitement around the promise of machines that can spit out living cells patterned to create three-dimensional biological structures.

But the dream of functional 3-D-printed tissue and organs has long been stymied by a stubborn central challenge: how to get blood to flow to keep the cells alive.

Now, Robbins reports, a team of researchers at the Wake Forest School of Medicine in North Carolina has made the latest contribution to solving the puzzle, though their findings are still a long way away from helping patients. Continue reading

FDA Issues Recommendations to Reduce Risk for Zika Virus Blood Transmission in the U.S.

Zika VirusWashington, DC, February 17, 2016 ― As a safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration (FDA) yesterday issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.

“The FDA has critical responsibilities in outbreak situations and has been working rapidly to take important steps to respond to the emerging Zika virus outbreak,” said Luciana Borio, M.D., the FDA’s acting chief scientist.  “We are issuing this guidance for immediate implementation in order to better protect the U.S. blood supply.”

While there have been no reports to date of Zika virus entering the U.S. blood supply, the risk of blood transmission is considered likely based on the most current scientific evidence of how Zika virus and similar viruses (flaviviruses) are spread and recent reports of transfusion-associated infection outside of the U.S. Continue reading

Join ‘I’m Not Average,’ A Community for Patients, Supporters; Follow on Facebook, Twitter

PhRMA's I'm Not Average CampaignWashington, DC, February 17, 2016 ― Every patient has a powerful story.  This is the core belief that inspired the creation of “I’m Not Average,” an online campaign committed to sharing stories of hope in the face of illness thanks, in part, to innovative treatments and modern medicines, posts Ieva M. Augstums on The Catalyst, the Pharmaceutical Research and Manufacturers of America’s (PhRMA) content-rich blog.

Join the online “I’m Not Average” community on Facebook and Twitter, and show your support for those that embody strength during hardship.

Augstums writes, “Whether you are a patient yourself like 9-year-old Ellie, a caregiver like Diane, or a general supporter, we hope that this community serves as a vehicle for inspiration and encouragement for those that need it.” Continue reading

Governor Christie Delivers Fiscal Year 2017 Budget Address

Chris Christie official portrait 2013Trenton, NJ, February 16, 2016 Governor Chris Christie this afternoon delivered his Fiscal Year 2017 budget address to members of the New Jersey Legislature. 

The following is the Governor’s address as prepared for delivery.

*     *     *

Senate President Sweeney, Speaker Prieto, Lieutenant Governor Guadagno, members of the New Jersey State Legislature, friends, and my fellow New Jerseyans:

Today I come before you to present my budget for Fiscal Year 2017.

This is the seventh time I have presented a budget to this chamber, and I’m proud to say this for a seventh time.

This budget is balanced. Continue reading